Anti-peptidylarginine deiminase-4 antibodies at mucosal sites can activate peptidylarginine deiminase-4 enzyme activity in rheumatoid arthritis

被引：0
|
作者：
M. Kristen Demoruelle
Hong Wang
Ryan L. Davis
Ashley Visser
Johnny Hoang
Jill M. Norris
V. Michael Holers
Kevin D. Deane
Erika Darrah
机构：
[1] University of Colorado Anschutz Medical Campus,Division of Rheumatology
[2] The Johns Hopkins University,Division of Rheumatology
[3] Colorado School of Public Health,undefined
来源：
Arthritis Research & Therapy | / 23卷
关键词：
Rheumatoid arthritis; Anti-PAD4 antibodies; Lung; Sputum; Saliva;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Anti-peptidylarginine deiminase-4 antibodies at mucosal sites can activate peptidylarginine deiminase-4 enzyme activity in rheumatoid arthritis
    Demoruelle, M. Kristen
    Wang, Hong
    Davis, Ryan L.
    Visser, Ashley
    Hoang, Johnny
    Norris, Jill M.
    Holers, V. Michael
    Deane, Kevin D.
    Darrah, Erika
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [2] Anti-Peptidylarginine Deiminase-4 Antibodies Are Present in the Sputum of RA Patients and Can Activate Peptidylarginine Deiminase-4 Enzyme Activity
    Demoruelle, M. Kristen
    Wang, Hong
    Davis, Ryan L.
    Marin, A. Itzam
    Norris, Jill M.
    Holers, V. Michael
    Deane, Kevin D.
    Darrah, Erika
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [3] Expression of anti-Porphyromonas gingivalis peptidylarginine deiminase immunoglobulin G and peptidylarginine deiminase-4 in patients with rheumatoid arthritis and periodontitis
    Shimada, A.
    Kobayashi, T.
    Ito, S.
    Okada, M.
    Murasawa, A.
    Nakazono, K.
    Yoshie, H.
    JOURNAL OF PERIODONTAL RESEARCH, 2016, 51 (01) : 103 - 111
  • [4] Prevalence and significance of anti-peptidylarginine deiminase 4 antibodies in rheumatoid arthritis
    Zhao, Jinxia
    Zhao, Yi
    He, Jing
    Jia, Rulin
    Li, Zhanguo
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (06) : 969 - 974
  • [5] Peptidylarginine Deiminase-4 Antibodies Are Not Associated with Worse RA Activity, Symptoms or Impacts
    DiRenzo, Dana
    Darrah, Erika
    Bartlett, Susan J.
    Bingham, Clifton O., III
    Cappelli, Laura C.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [6] Peptidylarginine deiminase-4: Medico-formulative strategy towards management of rheumatoid arthritis
    Thirugnanasambandham, Indhumathi
    Radhakrishnan, Arun
    Kuppusamy, Gowthamarajan
    Singh, Sachin Kumar
    Dua, Kamal
    BIOCHEMICAL PHARMACOLOGY, 2022, 200
  • [7] Smoking is not linked to the development of anti-peptidylarginine deiminase 4 autoantibodies in rheumatoid arthritis
    Cappelli, Laura C.
    Konig, Maximilian F.
    Gelber, Allan C.
    Bingham, Clifton O., III
    Darrah, Erika
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [8] Smoking is not linked to the development of anti-peptidylarginine deiminase 4 autoantibodies in rheumatoid arthritis
    Laura C. Cappelli
    Maximilian F. Konig
    Allan C. Gelber
    Clifton O. Bingham
    Erika Darrah
    Arthritis Research & Therapy, 20
  • [9] Serum igg antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis
    Halvorsen, E. H.
    Pollmann, S.
    Gilboe, I.
    van der Heijde, D.
    Landewe, R.
    Odegard, S.
    Kvien, T. K.
    Molberg, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 81 - 81
  • [10] Anti-Peptidylarginine Deiminase 4 Autoantibodies and Disease Duration as Predictors of Treatment Response in Rheumatoid Arthritis
    Cappelli, Laura C.
    Hines, David
    Wang, Hong
    Bingham, Clifton O.
    Darrah, Erika
    ACR OPEN RHEUMATOLOGY, 2024, 6 (02) : 81 - 90
12345